Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
December 21, 2023
Clinical and morphological features of large-cell neuroendocrine carcinomas and small-cell lung carcinomas expressing the DLL3 and ASCL1 oncoproteins
T G Prieto, C M Baldavira, J Machado-Rugolo, et al.
Scientific Reports
|
September 9, 2017
Tissue alkalosis in cold-ischemia time
V Denninghoff, E H R Olivieri, C Fresno, et al.
Archives of Biochemistry and Biophysics
|
August 1, 2006
Phosphate closes the solution structure of the 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) from Mycobacterium tuberculosis
Júlio C Borges, José H Pereira, Igor B Vasconcelos, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
April 12, 2023
Concomitant TP53 mutation in early-stage resected EGFR-mutated non-small cell lung cancer: a narrative approach in a genetically admixed Brazilian cohort
J Machado-Rugolo, C M Baldavira, T G Prieto, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
January 11, 2023
Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor
J Machado-Rugolo, C M Baldavira, T G Prieto, et al.
The Journal of Organic Chemistry
|
March 31, 2012
Synthesis of 4-substituted chlorophthalazines, dihydrobenzoazepinediones, 2-pyrazolylbenzoic acid, and 2-pyrazolylbenzohydrazide via 3-substituted 3-hydroxyisoindolin-1-ones
Hanh Nho Nguyen, Victor J Cee, Holly L Deak, et al.
Journal of Medicinal Chemistry
|
March 5, 2016
Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity
Laurie B Schenkel, Philip R Olivieri, Alessandro A Boezio, et al.
Nature Communications
|
June 10, 2014
Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour
Giovana T Torrezan, Elisa N Ferreira, Adriana M Nakahata, et al.
Cancer Research
|
October 12, 2010
Preclinical evaluation of AMG 900, a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines
Marc Payton, Tammy L Bush, Grace Chung, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 14, 2007
Synthesis, structural analysis, and SAR studies of triazine derivatives as potent, selective Tie-2 inhibitors
Brian L Hodous, Stephanie D Geuns-Meyer, Paul E Hughes, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
December 21, 2023
Clinical and morphological features of large-cell neuroendocrine carcinomas and small-cell lung carcinomas expressing the DLL3 and ASCL1 oncoproteins
T G Prieto, C M Baldavira, J Machado-Rugolo, et al.
Scientific Reports
|
September 9, 2017
Tissue alkalosis in cold-ischemia time
V Denninghoff, E H R Olivieri, C Fresno, et al.
Archives of Biochemistry and Biophysics
|
August 1, 2006
Phosphate closes the solution structure of the 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) from Mycobacterium tuberculosis
Júlio C Borges, José H Pereira, Igor B Vasconcelos, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
April 12, 2023
Concomitant TP53 mutation in early-stage resected EGFR-mutated non-small cell lung cancer: a narrative approach in a genetically admixed Brazilian cohort
J Machado-Rugolo, C M Baldavira, T G Prieto, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
January 11, 2023
Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor
J Machado-Rugolo, C M Baldavira, T G Prieto, et al.
The Journal of Organic Chemistry
|
March 31, 2012
Synthesis of 4-substituted chlorophthalazines, dihydrobenzoazepinediones, 2-pyrazolylbenzoic acid, and 2-pyrazolylbenzohydrazide via 3-substituted 3-hydroxyisoindolin-1-ones
Hanh Nho Nguyen, Victor J Cee, Holly L Deak, et al.
Journal of Medicinal Chemistry
|
March 5, 2016
Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity
Laurie B Schenkel, Philip R Olivieri, Alessandro A Boezio, et al.
Nature Communications
|
June 10, 2014
Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour
Giovana T Torrezan, Elisa N Ferreira, Adriana M Nakahata, et al.
Cancer Research
|
October 12, 2010
Preclinical evaluation of AMG 900, a novel potent and highly selective pan-aurora kinase inhibitor with activity in taxane-resistant tumor cell lines
Marc Payton, Tammy L Bush, Grace Chung, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 14, 2007
Synthesis, structural analysis, and SAR studies of triazine derivatives as potent, selective Tie-2 inhibitors
Brian L Hodous, Stephanie D Geuns-Meyer, Paul E Hughes, et al.
Page
of 5